Pulsenmore PLSM
NASDAQ PLSM
$2.94 -0.02 (-0.68%)
At close: Aug 21, 2026 · 4:00 PM EDT

Pulsenmore (PLSM) Accumulated Expenses (2025)

Pulsenmore (PLSM) posted Accumulated Expenses of $1.4 million for Q4 2025.

Pulsenmore (PLSM) Accumulated Expenses (2025) Analysis & Trends

Pulsenmore has reported Accumulated Expenses for 1 years, with the latest figure at $1.4 million in Q4 2025.

  • Quarterly Accumulated Expenses changed N/A year-over-year to $1.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.4 million (changed N/A YoY) and the FY2025 annual result came in at $1.4 million, changed N/A from the prior year.
  • Accumulated Expenses was little changed at $1.4 million in Q4 2025 per PLSM's latest filing.
  • Over five years, Accumulated Expenses peaked at $1.4 million in Q4 2025 and troughed at $1.4 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn
10 Pulsenmore 18.62 Mn -3.05 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.38 Mn